A respiratory syncytial virus vaccine (RSV vaccine) is a vaccine which prevents infection by respiratory syncytial virus. Respiratory syncytial virus (RSV) is a common and pervasive cause of acute respiratory illness.
Pfizer Inc. May 25th launched 'An Accord for a Healthier World.' This groundbreaking initiative aims to provide all of Pfizer's patented, high-quality medicines and...
Pfizer Inc. and ReViral Ltd. announced today that the companies have entered into a definitive agreement under which Pfizer will acquire ReViral, a privately...
Open Orphan plc., announces that hVIVO, a subsidiary of Open Orphan, has signed a £5m respiratory syncytial virus (RSV) human challenge study contract with...
Moderna, Inc., on Wednesday announced the finalization of a strategic partnership with the Australian Federal Government to establish a state-of-the-art, domestic mRNA vaccine manufacturing...
Bavarian Nordic announced, that it has entered into an exclusive license and supply agreement with Nuance Pharma, a Shanghai-based specialty pharmaceutical company, on the...